Search

The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality

Journal: Current Cancer Drug Targets
Volume: 18 Issue: 5 Year: 2018 Page: 480-498
Author(s): Sebastiano Bordonaro,Massimiliano Berretta,Antonino Carmelo Tralongo,Silvia Clementi,Brigida Stanzione,Paolo Tralongo

In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-anilinoacridines as HER2 Inhibitors Targeting Breast Cancer

Journal: Current Drug Research Reviews
Volume: 11 Issue: 2 Year: 2019 Page: 118-128
Author(s): Rajagopal Kalirajan,Arumugasamy Pandiselvi,Byran Gowramma,Pandiyan Balachandran

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

Journal: Current Cancer Drug Targets
Volume: 15 Issue: 8 Year: 2015 Page: 665-683
Author(s): Otília Menyhart,Libero Santarpia,Balazs Gyorffy

Auto-Analysis of Immunohistochemical Findings for Breast Cancer

Ebook: Advances in Modern Medicine
Volume: 1 Year: 2017
Author(s): Kazuya Kuraoka,Kiyomi Taniyama,Miho Yoshida-Tanaka,Akihisa Saito,Nao Morii,Shinji Ozaki
Doi: 10.2174/9781681080239117010007

Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors TargetingBreast Cancer - An in-silico approach

Journal: Current Drug Research Reviews
Volume: 14 Issue: 1 Year: 2022 Page: 61-72
Author(s): Kalirajan Rajagopal,Vulsi Bodhya Sri,Gowramma Byran,Swaminathan Gomathi

The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development

Journal: Current Cancer Drug Targets
Volume: 4 Issue: 3 Year: 2004 Page: 235-256
Author(s): Constantine S. Mitsiades, Nicholas Mitsiades, Michael Koutsilieris

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast

Journal: Current Cancer Drug Targets
Volume: 8 Issue: 4 Year: 2008 Page: 243-252
Author(s): Kazumori Arai, Sachiko Takano, Takumi Teratani, Yasuhiro Ito, Toshihiro Yamada, Ryushi Nozawa

Optimizing Tumor-Reactive γδT Cells for Antibody-Based Cancer Immunotherapy

Journal: Current Molecular Medicine
Volume: 10 Issue: 8 Year: 2010 Page: 719-726
Author(s): S. Meraviglia, N. Caccamo, G. Guggino, M. Tolomeo, S. Siragusa, G. Stassi, F. Dieli

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 6 Year: 2011 Page: 714-733
Author(s): M. W. Wiedmann, J. Mossner

Evaluation of Hydrazide-hydrazone and 4-thiazolidinone Derivatives of Etodolac as Potential Anticancer Agents in Leukemia Cells

Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 12 Year: 2024 Page: 2396-2406
Author(s): Pinar Mega Tiber,Sevgi Koçyiğit Sevinç,Pelin Çikla Süzgün,S. Güniz Küçükgüzel